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Abstract: 
Objective 
A dearth of information exists in the literature regarding current practice in the 
management of Klippel-Trenaunay Syndrome (KTS), a rare condition.  We seek to 
review and describe the etiology, diagnosis, and treatment of the KTS patient. 
Methods 
Relevant data was synthesized from a Medline review using a combination of key 
terms “Klippel” and “Trenaunay”.  Majority of hits described singular case reports and 
were subsequently excluded.  Remaining papers were then reviewed and included based 
on quality of evidence and author discretion.    
Conclusion 
KTS is characterized by a clinical triad of extremity varicosities, cutaneous 
vascular malformations, and hypertrophy of soft tissues and/or long bones.  The diagnosis 
is clinically supplemented with MRI and CT scanning.  Although this syndrome is 
associated with significant comorbidities such as pain, edema, ulcerations, and pruritus – 
it is rarely the cause of mortality. The backbone of treatment is nonoperative in nature but 
should be supplemented with minimally invasive, endovascular, and rarely open surgical 
procedures for refractory cases.   
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Introduction: 
 
Vascular malformations of Klippel-Trenaunay syndrome (KTS) usually affect the 
capillary, venous, and lymphatic systems of the lower extremities.  Rarely, these defects 
are seen in the upper extremities, are bilateral, or involve the trunk.  Although first 
described by Hilaire in 1832, KTS was truly recognized as an entity in itself by its 
namesakes at the turn of the 20th century.(1)  The duo of Frenchmen defined a cohort of 
patients presenting with a triad of asymmetric limb hypertrophy, localized capillary 
malformation (nevus flammeus, “port-wine stain”), and congenital lower extremity 
varicosities.  Although KTS is generally benign in course, the diseased limb can exhibit 
pain, swelling, hyperpigmentation, thrombophlebitis, variceal bleeding, and ulceration. 
 
Shortly after description by Klippel and Trenaunay, Weber designated a similar 
vascular syndrome with the addition of arteriovenous fistulas (AVFs) termed the Parkes-
Weber Syndrome (PWS).(2)  This separate pathology has been the source of much 
confusion since the mid-20th century as clinicians have often ascribed one as the other.  
However, there are crucial differences which affect the clinical course.  With addition of 
high flow AVFs, those suffering from PWS have a decreased lifespan and more 
significant arterial complications compared to the more benign KTS.   
 
 Much effort has been made to unify the criteria of KTS in order to clarify the 
clinical condition, the first step in diagnosis and management.  Currently, the best 
classification of venous malformations, of which KTS is one, is the Hamburg 
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Classification of Congenital Vascular Malformations.  Utilizing this tool, KTS would be 
classified as a predominantly venous defect of the truncular anatomic form presenting 
with aplasia, obstruction, and/or dilatation.  Truncular forms arises after developmental 
arrest and during vascular trunk formation; in other words, these lesions do not have the 
ability to proliferate after removal.(3, 4)  
 
The true pathogenesis of KTS has been elusive.  While most patients demonstrate 
a normal karyotype, sporadic translocations have been reported of chromosomes 5-11 and 
8-14; a supernumerary ringed chromosome 18 have also been described.  Familial cases 
are rarely (and often unreliably) reported.(5)  The affected limbs tend to exhibit increased 
blood flow; this has been thought related to VEGF-mediated angiogenesis, but no 
definitive evidence has been brought forth.  There also may be involvement of gain-of-
function PIK3CA gene mutations causing upregulation of AKT and mTOR signaling.(6)  
PI3K and mTOR inhibitors are currently being investigated as treatment options with 
promising results in mice and humans.(7-9)  At least 6 hypothetical causes of KTS have 
been suggested in the literature; of which, none completely explains the entire clinical 
spectrum.(5)  
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Presentation: 
 
KTS is clinically diagnosed by the observation of a triad of cutaneous capillary 
malformations, varicosities, and hypertrophy soft tissues and/or long bones.  However, a 
spectrum and combination of the aforementioned is usually appreciated in the real world.  
In addition, while this classical presentation is usually observed in a singular limb, 
multiple and even whole body cases have been described.(10) 
 
Limb length discrepancy is most often secondary to underlying soft tissue growth 
but can be associated with long bone hypertrophy.  The difference in growth occurs 
during childhood before stabilizing in young adulthood with minimal changes after the 
teenage years.(11)   
 
Capillary malformations present on the hypertrophied limb and clinically appear 
as flat hemangiomas.  In contrast, true flow-limiting arterial pathology is exceedingly rare 
in KTS and more characteristic of the more pathologic PWS.  A cutaneous capillary 
malformation is often the first and most obvious sign on examination of the patient 
suspected of KTS.  This is often referred to in the literature as a “port-wine stain”.  
Frequently dermatomal in distribution, these lesions tend to bleed and persist as the 
patient ages.  The frequency of which these skin findings coexist in KTS cannot be 
understated; in fact, the prevalence of capillary malformations approaches 100% in the 
reported literature.(12)    
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Varicosities usually appear on the lateral aspect of the limb resulting from 
persistent embryonic veins, superficial venous malformations, or as a result of deep 
venous aberrations consisting of hypoplasia, segmental aplasia, and aneurysmal 
degeneration.(2, 13)  Varicosities are slightly less common than capillary malformations 
and range from 76-100% in small case series (Figure 1).(12)  These pathologic vessels 
disappear proximally as the diseased veins dive into the proximal femoral and iliac 
systems.  Patients mainly complain of swelling, often with pain, but may also experience 
more advanced clinical signs and symptoms of chronic venous disease.(14, 15) 
 
Frequently, patients present with a persistent embryonic vein on the lateral aspect 
of the distal leg termed a “lateral marginal vein” or “persistent sciatic vein”.  Prevalence 
rates in the literature range from 9-68%.(13, 15-19)  Animal fetal studies have demonstrated 
these embryonic veins form and regress by 12-weeks of life, but this has yet to be 
demonstrated in humans.(19) 
 
Yamaki et al reported the frequency of venous and lymphatic malformations in 61 
KTS patients clinically diagnosed with duplex and MRI.  Capillary malformations were 
detected in 89%, among which port-wine stain was most prominent (66%), followed by 
telangiectasia (51%) and angiokeratoma (30%).  A persistent embryonic vein was 
detected in 53% of the patients.  Reflux was observed in the GSV (20%), embryonic vein 
(15%), and SSV (7%).  Deep vein hypoplasia/aplasia was observed in 20%.  
Extratruncular and truncular lymphatic malformations were observed in 21% and 28% of 
the patients respectively.(20)      
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The signs and symptoms of KTS are often related to the obstruction or 
insufficiency present in the venous outflow and can be scored using the CEAP 
classification system for chronic venous disease (clinical presentation, etiology, anatomic 
involvement, and pathophysiology).(3, 21)  Furthermore, the results of any treatment 
should be determined using Venous Severity Scores and Quality of Life questionnaires 
used for more familiar forms of chronic venous disorders.(3, 15, 22)    
 
 If internal organs are affects by vascular malformations, patients may report mild 
hematuria or hematochezia.(23)  In a small, and unfortunate subpopulation, bleeding may 
be intractable and necessitate bowel resection.(10)   
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Diagnosis: 
 
The diagnosis of KTS is clinical and difficult to make even for the experienced 
physician as there is no true pathognomonic test.  However, an elevated D-dimer and 
mutation of the AGGF1 gene may suggest the diagnosis.(4)  The status of the PIK3CA 
gene does not currently add diagnostic value but may yield useful information in the 
future.(24)  Duplex ultrasonography, Magnetic Resonance (MR) imaging, and 
Computerized Tomographic (CT) imaging may show soft tissue hypertrophy and 
associated vascular malformations.  Plain films can be used to screen long bones for limb 
length discrepancies. 
 
Patients suspected of KTS should be initially evaluated with noninvasive imaging.  
The purpose of which is to determine the extent and severity of disease along with 
delineation of any significant arteriovenous shunting which may be present.(21)  
 
The high sensitivity and specificity of lower extremity duplex imaging in regards 
to venous and arterial anatomy and function makes it the best initial diagnostic study.(16)  
Confirmation can be easily obtained of valvular incompetence, low-flow regions, 
compressible vascular channels, and anatomical abnormalities such as aneurysms or 
atretic segments quickly, at low cost, and without the need for sedation in the pediatric 
population.  In addition to B-mode and color flow, hemodynamic studies such as 
ankle/brachial indices, segmental pressures, and pulse volume recordings may be useful 
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in flushing out suspected arterial anomalies such as the blunted waveforms and reduced 
digital pressures observed distal to a high flow AVM. 
 
Most consider MR imaging essential in the diagnostic evaluation of patients with 
KTS as it allows differentiation of the soft tissues.  This modality can provide the first 
assessment of the involvement of muscles, joints, and bones.  Also, the addition of IV 
gadolinium contrast can discriminate venous from the more insidious arterial 
malformations and help the classification of patients into the Hamburg system.(21)  
 
CT imaging incurs a radiation dose along with potential renal toxicity depending 
on patient’s prestudy renal function and contrast usage.  It may not provide detail of 
muscle and surrounding soft tissue involvement, for which the MR excels.  Additionally, 
many patients undergoing initial evaluation for KTS are children, making the avoidance 
of radiation all the more important.  However, contrast CT imaging with venous phase 
protocols may be of particular use in preinterventional planning and cannot be avoided at 
times despite the best intentions.  
 
Lastly, ascending venography should be employed to assist with preoperative 
planning when superficial vein eliminating procedures such as ablation, sclerotherapy, 
ligation, or stripping are planned as it can be performed concurrently.  If documentation 
of a patent deep venous system has not been performed previously, venography can assist 
with this as well. 
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The differential diagnosis for patients being considered for KTS should include 
Sturge-Weber syndrome, Parkes-Weber syndrome, lymphatic filariasis, Beckwith-
Wiedemann syndrome, Russell-Silver syndrome, CHILD syndrome, NF1, triploid 
syndrome, and Proteus syndrome.(24)  The differences in presentation of these complex 
disease states are briefly delineated in table I.  The plethora of named syndromes makes 
the Hamburg classification so appealing in that it provides a structure and delivers 
direction to treatment.   
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Medical Management: 
 
Non-operative medical management is the main modality in the treatment of 
symptomatic KTS patients.  Rarely, and only in patients refractory to medical 
management, should operative intervention be considered.  For example, in a series of 19 
KTS patients reported by Sung et al, only 4 underwent operative intervention during a 
mean follow-up of 4.1 years with no major adverse outcomes regardless of management 
style.(14) 
 
Patients with KTS should be managed similarly to those with more common 
varieties of chronic venous disorders with appropriate consideration of potentially 
extenuating circumstances such as deep venous agenesis (Figure 2).  The latter may make 
the remaining superficial veins a very important egress for lower extremity outflow.   
 
 Patients presenting with symptoms of chronic venous disease should be initiated 
on a regimen of compression and elevation.  This is the fundamental basis of all treatment 
related to limb edema.  Compression stockings should extend from above the affected 
area to the digits and should be fitted to the individual limb.  The correct pressure may 
vary for the patient but typically ranges from 20-40 mmhg.  However, compliance to this 
garment can be difficult in the pediatric population with rapidly growing limbs along 
with other social factors.  Low-dose aspirin should be considered as there is limited 
benefit to pain and swelling in patients with vascular malformations.(25)  If symptoms are 
refractory to compression alone, intermittent pneumatic compression can be an useful 
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adjunct in lower extremity edema mobilization.(26)  Some clinicians will trial a course of 
diuretics in the patient with continued symptomatic edema despite compression, 
mobilization, and elevation; however, there is no evidence of efficacy in reduction of 
limb edema.(17) 
 
If soft tissue inflammation develops, it should initially be managed with over the 
counter analgesics and elevation.  Be mindful this presentation is often initially sterile; 
therefore, antibiotics should be reserved until cellulitis with virulent organisms is 
suspected.(17)  Wound cultures can be performed, however, organisms are rarely isolated.  
There is currently no evidence for prophylactic antibiotics in this population.  
Additionally, the need for careful wound care and personal hygiene should be reinforced 
with each clinic visit.  
 
No role for anticoagulation has been identified early in the clinical course; 
however, it should be initiated if patients develop deep venous thrombosis (DVT).  
Additionally, adults who have had a venous intervention should be considered for a short 
perioperative course of prophylaxis, as they have increased risk for thromboembolic 
events.(11)  Additionally, women with severe venous malformations should avoid oral 
contraceptives as this has been associated with a higher risk of thromboembolic 
events.(17) 
 
Limb length discrepancies can be appropriately managed with heel inserts or 
compensatory shoes to avoid scoliosis as long as discrepancies are less than 1.5cm.  
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However, if the discrepancy in limb length is greater than 2cm, surgical intervention 
should be considered in the form of osteotomy or epiphysiodesis by the appropriately 
trained orthopedic surgeon. 
 
Using the CEAP classification, operative vascular intervention should be 
considered when the severity of disease progresses to greater than class 3 or potentially 
class 2 in some symptomatic cases.(27)  The largest experience of vascular malformations 
intervened upon are reported by Mayo Clinic.  In their practice, absolute indications for 
intervention consists of continuing hemorrhage, refractory ulcerations, and acute 
thromboembolism.  Relative indications consists of pain, functional impairment, swelling 
secondary to venous insufficiency, limb asymmetry, and cosmesis.(21)   
 
Because of the rarity and complexity of KTS, early referral to specialist centers 
should be considered.(24)  The varying presentations and severity of disease necessitates 
that each treatment plan be individualized for the specific KTS patient.  Additionally, a 
multidisciplinary team should be involved with the patient’s care so that all needs are 
addressed as they manifest.  Perhaps the most important member of the team is the 
patient.  He/she should be educated regarding the nature of their disease as compliance to 
any proposed treatment is essential to ultimate success and only increases with education.   
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Endovascular and Minimally Invasive Intervention: 
 
The role of endovascular therapy and minimally invasive intervention in KTS is 
not well-established secondary to the low prevalence of the disease; however, it should be 
offered over open surgery after failed nonoperative management.  The basis of the 
success of sclerotherapy, embolization, ablation, and laser treatments in KTS are built 
from the parallel experience in chronic venous and capillary disease.  
 
A plastic surgery group from South Korea described pulsed dye laser therapy in 
their KTS population for capillary malformations, namely port-wine stains.  4 of their 
small series of 19 patients were treated with laser without morbidity.  The 585nm 
wavelength has also been effectively used in the treatment of facial telangiectasias and 
hemangiomas.(14)  The clinician should keep in mind lighter colored lesions in the 
pediatric population respond best while darker lesions in adults are more refractory to 
treatment; however, these darker lesions are responsive to nontraditional Krypton and 
copper lasers.(28)       
 
After failed non-operative management of varicosities, sclerotherapy or 
embolization (Figure 3) techniques with various agents can be attempted.  However, 
before intervention is performed, the deep venous system should be documented to be 
patent by imaging of choice.  These techniques, over RFA ablation, should be considered 
for persistent embryonic and large superficial veins to avoid post-operative persistence of 
hard cords and thermal injury.(24)  In particular, the persistent sciatic vein should be 
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treated with sclerotherapy or embolization secondary to close proximity of the sciatic 
nerve.(24, 29)   
 
Burrows et al reported their series of consecutive sclerotherapy patients with low 
flow vascular malformations and noted a good or excellent result in up to 90% of patients 
by clinical survey.  However, there was a complication rate of 12% per treatment and a 
28% complication rate per patient.  Almost 15% of the patients in this series had some 
evidence of skin necrosis.  To decrease the high-risk of complications, the authors 
cautioned against injection of agents, especially ethanol, close to major nerves or 
cutaneous lesions.(30)  Later reports have echoed these initial findings.(31) 
 
Foam sclerotherapy has also been well documented in the literature.  Smith 
reports a series of 808 mostly CEAP class 2 patients undergoing ultrasound-guided 
injection with diluted sodium tetradecyl.  Although follow-up was marginal, there was a 
significant decrease in CEAP classification 6 months after the procedure.  Minor 
complications were minimal, and the author reported no major complications.(32)  
 
Endovascular radiofrequency ablation of the persistent embryonic or GSV has 
also increasingly gained popularity over the last 10 years.  Weiss et al reports 934 
consecutive radiofrequency and laser thermal ablations of superficial veins with 6-month, 
1-year, and 5-year ablation rates at 92%, 86%, and 72% respectively.(33)  No differences 
were noted in the laser and radiofrequency ablation groups.  Smaller series on KTS 
patients also mirror these excellent results, although retreatment is common, with 
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minimal complications.(34)  As with superficial veins in any patient, care has to be taken 
when using these modalities and no heat sink can be provided during the procedure.  The 
result could be significant cutaneous burns.(35)     
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Open Surgery: 
 
Although some advocate for early surgical intervention,(36) open surgical volume 
has drastically decreased over the last several decades and become more of historical 
interest secondary to wound complications and persistent bleeding.  Currently, open 
operations are reserved for patients who are not candidates for minimally invasive 
techniques and, therefore, mainly consist of a combination of high ligation of persistent 
embryonic veins, vein stripping, and stab phlebectomies.  Subfascial endoscopic 
perforator surgery (SEPS) has been useful in the select group of patients with large and 
incompetent perforating veins but new available percutaneous interventions are making 
this of historical significance as well. 
 
Ulcerated or bleeding lesions may be excised when possible; however, the 
clinician should keep in mind the poor wound healing potential of the KTS limb.(37)  
Therefore, post-operative edema should be kept to a minimum with compression and 
elevation as tolerated.  Before intervention, the venous anatomy should be meticulously 
documented to avoid destroying the superficial venous system in patients with an atretic 
deep system.   
 
Because of the robust venous network that can develop in these patients, 
consideration should be given to the potential blood loss during an open operation.  
Blood should be available in the operating theatre to transfuse as needed.  Additionally, 
tourniquets can be an important adjunctive tool and should be used when appropriate.(12) 
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The largest open surgical series comes from the French surgeon Servelle who 
described 786 “KTS” operations over 40 years of practice in 1985.  Although the author 
claimed all patients were clinically diagnosed with KTS, 71% of the operations were 
performed for venous compression release in the extremities, not a problem often seen in 
the KTS population.  Only 36% of the cohort had clinically apparent varicosities while 
port-wine stains were only present in 32%.  Follow-up and outcomes were not 
reported.(18)    
 
Baraldini et al reported their experience of 29 pediatric KTS patients undergoing 
a combination of open and minimally invasive interventions for venous disease.  Average 
age of intervention was 10.3 years.  The procedures were all technically successful.  No 
mortalities or major complications were noted on 6-month and 2-year follow-up.  The 
authors suggest early intervention is safe and efficacious in minimizing long-term venous 
hypertension and its sequelae.(36) 
 
The Mayo Clinic group documented their surgical experience longitudinally in 
consecutive KTS patients over two decades previous to the widespread adoption of RFA 
and laser ablation.  One such report describes intervention in 53 limbs of 49 patients.  The 
average length of follow up was 73 months.  All had varicosities, 73% had limb 
hypertrophy, and all patients met two of the three diagnostic KTS criteria.  The most 
common presenting symptom was disabling pain (88%).  Stripping of the GSV, small 
SV, and lateral embryonic vein was undertaken in 32%, 36%, and 28% respectively.  
 19 
Short-term morbidity included a 4% DVT risk, a 14% thrombophlebitis rate, and 10% 
experienced at least one episode of cellulitis.  There were no deaths.  13/49 patients 
required reintervention.  Nonetheless, 50% reported significant pain relief and 
statistically significant decreases in VCSS and CEAP scores were reported.(12)  
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Conclusion: 
 
Klippel-Trenaunay Syndrome is characterized by a triad of cutaneous vascular 
malformations in the form of port-wine stains, limb length discrepancies, and venous 
insufficiency secondary to venous malformations.   
 
The diagnosis of this disease is clinical but can be supplemented with noninvasive 
imaging such as duplex sonography to define the lower extremity venous anatomy.  
Radiological studies such as MR (primarily) and CT imaging can further delineate the 
deep and superficial venous anatomy as well as adjacent soft tissue, joint, muscle and 
bony involvement so needed for preoperative planning.   
 
Primary treatment consists of nonoperative management with lifestyle 
modification, local wound care, orthotics, extremity elevation, and compression therapy.  
Operative intervention is rarely required.  If symptom progression occurs, patients should 
be offered a combination of pulsed laser therapy, embolization, sclerotherapy with foam 
or ethanol, and/or radiofrequency or laser ablation.   
 
Patients who are not candidates for minimally invasive techniques may benefit 
from open surgery consisting of vein stripping, stab phlebectomies, or more aggressive 
venous reconstructions.  It is important to image the deep system to confirm patency prior 
to removal of flow from the superficial system.  
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Legends 
 
 
Figure 1.  Patient with unilateral limb swelling secondary to persistent lateral marginal 
vein (yellow arrow) and varicosities (red arrow) since birth.  A large and diffuse port-
wine stain is noted over the posterior aspect of the right thigh (green arrow).   
 
Figure 2A.  Representative axial cut of a lower extremity MRV in which an absent deep 
vein is noted in the left lower extremity (smaller pink arrow).  A large persistent and 
patent lateral marginal vein appears to drain most of the left lower extremity.  Normal 
venous anatomy is noted in the right lower extremity and highlights the normal popliteal 
vein (stout smaller yellow arrow). 
 
Figure 2B.  Coronal section of the patient in 2A demonstrating a normal deep vein on the 
right side (yellow arrow).  On the left side, the deep veins are atretic (red arrow) and 
there is a large lateral subcutaneous vein (blue arrow) draining the left lower extremity.  
 
Figure 3A.  Axial sections from an MRV demonstrating a large left lower extremity 
persistent lateral marginal vein (large blue arrow) in addition to a normal patent popliteal 
vein (small red arrow).  The opposite side is normal with the popliteal vein highlighted by 
a yellow arrow.   
 
Figure 3B. Representative intraoperative imaging of the same patient as Figure 3A in 
which the lateral marginal vein was cannulated and subsequently embolized using metal 
coils. 
 
The first panel is an image of the large lateral vein (green arrow) with only a perforator 
vein (blue) connecting it to the popliteal vein (yellow).  The second panel demonstrates 
occlusive coils lying within the abnormal lateral vein.    
 
 
 
 
Table I.  Differential diagnosis and the presentation of the various syndromes and 
diseases in the patient suspected of KTS 
 
